Immediate Impact

7 from Science/Nature 80 standout
Sub-graph 1 of 22

Citing Papers

Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering
2023 StandoutScience
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
2023 Standout
10 intermediate papers

Works of Robert G. Moses being referenced

A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
2015
A randomized controlled trial of the efficacy and safety of saxagliptin as add‐on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
2013
and 3 more

Author Peers

Author Last Decade Papers Cites
Robert G. Moses 1546 972 970 95 2.7k
Roberto Miccoli 816 1360 794 121 3.3k
A. Di Benedetto 1123 464 673 82 2.5k
Graziano Di Cianni 1468 640 666 82 2.1k
Nisha I. Parikh 814 430 525 98 3.9k
Harold W. de Valk 1190 1414 810 116 3.3k
Ester Vitacolonna 722 744 593 77 2.9k
Glynis P. Ross 1874 582 1068 73 2.7k
Rosa Corcoy 2272 1171 1389 141 3.6k
Ponnusamy Saravanan 885 1295 424 116 3.4k
Jencia Wong 807 1107 680 75 2.6k

All Works

Loading papers...

Rankless by CCL
2026